Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
Honton B, Lipiecki J, Monségu J, Leroy F, Benamer H, Commeau P, Motreff P, Cayla G, Banos JL, Bouchou G, Laperche C, Farah B, Rangé G, Lefèvre T, Amabile N; French Initiative Collaborators. Honton B, et al. Among authors: lipiecki j. Int J Cardiol. 2022 Oct 15;365:106-111. doi: 10.1016/j.ijcard.2022.07.023. Epub 2022 Jul 21. Int J Cardiol. 2022. PMID: 35870637
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry.
Lipiecki J, Rampat R, Piot C, Benamer H, Brunelle F, Lefèvre T, El Mahmoud R, Varenne O, Gommeaux A, Malquarti V, Angoulvant D, Cruchon C, Oldroyd K, Spaulding C. Lipiecki J, et al. J Invasive Cardiol. 2022 May;34(5):E363-E368. doi: 10.25270/jic/21.00258. Epub 2022 Apr 22. J Invasive Cardiol. 2022. PMID: 35451995 Free article.
Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry.
Maupas E, Lipiecki J, Levy R, Faurie B, Karsenty B, Moulichon ME, Brunelle F, Maillard L, de Poli F, Lefèvre T. Maupas E, et al. Among authors: lipiecki j. Catheter Cardiovasc Interv. 2017 Nov 15;90(6):890-897. doi: 10.1002/ccd.27081. Epub 2017 May 22. Catheter Cardiovasc Interv. 2017. PMID: 28544186 Free PMC article.
Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results.
Koning R, Eltchaninoff H, Commeau P, Khalife K, Gilard M, Lipiecki J, Coste P, Bedossa M, Lefèvre T, Brunel P, Morice MC, Maillard L, Guyon P, Puel J, Cribier A; BESMART (BeStent in Small Arteries) Trial Investigators. Koning R, et al. Among authors: lipiecki j. Circulation. 2001 Oct 2;104(14):1604-8. doi: 10.1161/hc3901.096695. Circulation. 2001. PMID: 11581136 Clinical Trial.
Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group.
Carrié D, Khalifé K, Citron B, Izaaz K, Hamon M, Juiliard JM, Leclercq F, Fourcade J, Lipiecki J, Sabatier R, Boulet V, Rinaldi JP, Mourali S, Fatouch M, El Mokhtar E, Aboujaoudé G, Elbaz M, Grolleau R, Steg PG, Puel J; Benefit Evaluation of Direct Coronary Stenting Study Group. Carrié D, et al. Among authors: lipiecki j. Am J Cardiol. 2001 Mar 15;87(6):693-8. doi: 10.1016/s0002-9149(00)01485-5. Am J Cardiol. 2001. PMID: 11249885 Clinical Trial.
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators. Urban P, et al. Among authors: lipiecki j. N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14. N Engl J Med. 2015. PMID: 26466021 Free article. Clinical Trial.
Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
Mauler-Wittwer S, Sievert H, Ioppolo AM, Mahfoud F, Carrié D, Lipiecki J, Nickenig G, Fajadet J, Eckert S, Morice MC, Garot P. Mauler-Wittwer S, et al. Among authors: lipiecki j. JACC Cardiovasc Interv. 2022 Aug 22;15(16):1639-1648. doi: 10.1016/j.jcin.2022.05.036. Epub 2022 Jul 27. JACC Cardiovasc Interv. 2022. PMID: 35981838 Free article.
59 results